17 Aug Describe the cut scores for “normal” versus “at-risk” and/or “clinically significant.”
II. Test and Assessment Development Analysis: Test One: WAIS-IV
E. Describe the cut scores for “normal” versus “at-risk” and/or “clinically significant.”
F. Assess any cultural concerns for their impact on the effectiveness of the administration of the
test.
G. Determine if there are any ethical issues related to administering the test.
H. Assess the methods of interpreting and communicating the results (e.g., scaled scores,
percentile ranks, z-scores, t-scores) for their appropriateness.
III. Test and Assessment Development Analysis: Test Two: MMPI-2
E. Describe the cut scores for “normal” versus “at-risk” and/or “clinically significant.”
F. Assess any cultural concerns for their impact on the effectiveness of the administration of the
test.
G.are any ethical issues related to administering the test.
H. Assess the methods of interpreting and communicating the results (e.g., scaled scores,
percentile ranks, z-scores, t-scores) for their appropriateness.
IV. Clinical Formulation
A. Analyze the results of the tests using industry-standard tools.
B. Determine a diagnosis based on the data provided.
C. Interpret the psychometric data from the test results to address the reason for the referral.
